2[MD=9.75, 95%CI (8.27-11.27), P<0.01] and SaO2[MD=5.32, 95%CI (3.14-7.50), P<0.01], significantly reduced the PaCO2[MD=-6.99, 95%CI (-7.68--6.29), P<0.01]; and reduce the time of hospitalization[MD=-3.62, 95%CI (-4.07--3.06), P<0.01]. There was no adverse reaction in two groups. Conclusion For patients with AECOPD combined with respiratory failure, naloxone combined with NIPPV can significantly improve the clinical efficacy, reduce mortality and re-intubation rate, improve blood gas analysis index, and shorten the time of hospitalization."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁 > 過刊瀏覽>2018年第41卷第12期 >2018,41(12):2340-2348. DOI:10.7501/j.issn.1674-6376.2018.12.042
上一篇 | 下一篇

納洛酮聯(lián)用無創(chuàng)正壓通氣治療慢性阻塞性肺病合并呼吸衰竭的Meta-分析

Meta-analysis of naloxone combined with noninvasive positive pressure ventilation for treatment of acute exacerbation of chronic obstructive pulmonary with respiratory failure

發(fā)布日期:2018-12-17
您是第位訪問者
藥物評價研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號:(津)-非經(jīng)營性-2015-0031